These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 28791425)
61. Norisoboldine suppresses osteoclast differentiation through preventing the accumulation of TRAF6-TAK1 complexes and activation of MAPKs/NF-κB/c-Fos/NFATc1 Pathways. Wei ZF; Tong B; Xia YF; Lu Q; Chou GX; Wang ZT; Dai Y PLoS One; 2013; 8(3):e59171. PubMed ID: 23536866 [TBL] [Abstract][Full Text] [Related]
62. Interleukin-27 inhibits human osteoclastogenesis by abrogating RANKL-mediated induction of nuclear factor of activated T cells c1 and suppressing proximal RANK signaling. Kalliolias GD; Zhao B; Triantafyllopoulou A; Park-Min KH; Ivashkiv LB Arthritis Rheum; 2010 Feb; 62(2):402-13. PubMed ID: 20112358 [TBL] [Abstract][Full Text] [Related]
63. Angelica sinensis extract inhibits RANKL-mediated osteoclastogenesis by down-regulated the expression of NFATc1 in mouse bone marrow cells. Kong L; Zhao Q; Wang X; Zhu J; Hao D; Yang C BMC Complement Altern Med; 2014 Dec; 14():481. PubMed ID: 25496242 [TBL] [Abstract][Full Text] [Related]
64. Identification of NFAT binding sites that mediate stimulation of cathepsin K promoter activity by RANK ligand. Balkan W; Martinez AF; Fernandez I; Rodriguez MA; Pang M; Troen BR Gene; 2009 Oct; 446(2):90-8. PubMed ID: 19563866 [TBL] [Abstract][Full Text] [Related]
65. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically. Valverde P; Tu Q; Chen J J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638 [TBL] [Abstract][Full Text] [Related]
66. Estrogen-related receptor γ negatively regulates osteoclastogenesis and protects against inflammatory bone loss. Kim HJ; Kim BK; Ohk B; Yoon HJ; Kang WY; Cho S; Seong SJ; Lee HW; Yoon YR J Cell Physiol; 2019 Feb; 234(2):1659-1670. PubMed ID: 30076703 [TBL] [Abstract][Full Text] [Related]
67. A medium-chain fatty acid, capric acid, inhibits RANKL-induced osteoclast differentiation via the suppression of NF-κB signaling and blocks cytoskeletal organization and survival in mature osteoclasts. Kim HJ; Yoon HJ; Kim SY; Yoon YR Mol Cells; 2014 Aug; 37(8):598-604. PubMed ID: 25134536 [TBL] [Abstract][Full Text] [Related]
68. The tethering function of mitofusin2 controls osteoclast differentiation by modulating the Ca Ballard A; Zeng R; Zarei A; Shao C; Cox L; Yan H; Franco A; Dorn GW; Faccio R; Veis DJ J Biol Chem; 2020 May; 295(19):6629-6640. PubMed ID: 32165499 [TBL] [Abstract][Full Text] [Related]
69. KCNK1 inhibits osteoclastogenesis by blocking the Ca2+ oscillation and JNK-NFATc1 signaling axis. Yeon JT; Kim KJ; Chun SW; Lee HI; Lim JY; Son YJ; Kim SH; Choi SW J Cell Sci; 2015 Sep; 128(18):3411-9. PubMed ID: 26208638 [TBL] [Abstract][Full Text] [Related]
71. Cooperation of PU.1 With IRF8 and NFATc1 Defines Chromatin Landscapes During RANKL-Induced Osteoclastogenesis. Izawa N; Kurotaki D; Nomura S; Fujita T; Omata Y; Yasui T; Hirose J; Matsumoto T; Saito T; Kadono Y; Okada H; Miyamoto T; Tamura T; Aburatani H; Tanaka S J Bone Miner Res; 2019 Jun; 34(6):1143-1154. PubMed ID: 30721543 [TBL] [Abstract][Full Text] [Related]
72. Arctigenin inhibits osteoclast differentiation and function by suppressing both calcineurin-dependent and osteoblastic cell-dependent NFATc1 pathways. Yamashita T; Uehara S; Udagawa N; Li F; Kadota S; Esumi H; Kobayashi Y; Takahashi N PLoS One; 2014; 9(1):e85878. PubMed ID: 24465763 [TBL] [Abstract][Full Text] [Related]
73. RANKL induces NFATc1 acetylation and stability via histone acetyltransferases during osteoclast differentiation. Kim JH; Kim K; Youn BU; Jin HM; Kim JY; Moon JB; Ko A; Seo SB; Lee KY; Kim N Biochem J; 2011 Jun; 436(2):253-62. PubMed ID: 21413932 [TBL] [Abstract][Full Text] [Related]
74. Anti-osteoclastogenic activity of matairesinol via suppression of p38/ERK-NFATc1 signaling axis. Choi SW; Park KI; Yeon JT; Ryu BJ; Kim KJ; Kim SH BMC Complement Altern Med; 2014 Jan; 14():35. PubMed ID: 24444335 [TBL] [Abstract][Full Text] [Related]
75. TNF Induction of NF-κB RelB Enhances RANKL-Induced Osteoclastogenesis by Promoting Inflammatory Macrophage Differentiation but also Limits It through Suppression of NFATc1 Expression. Zhao Z; Hou X; Yin X; Li Y; Duan R; Boyce BF; Yao Z PLoS One; 2015; 10(8):e0135728. PubMed ID: 26287732 [TBL] [Abstract][Full Text] [Related]
76. A novel RANKL-targeted flavonoid glycoside prevents osteoporosis through inhibiting NFATc1 and reactive oxygen species. Hong G; Chen Z; Han X; Zhou L; Pang F; Wu R; Shen Y; He X; Hong Z; Li Z; He W; Wei Q Clin Transl Med; 2021 May; 11(5):e392. PubMed ID: 34047464 [TBL] [Abstract][Full Text] [Related]
77. RGS10-null mutation impairs osteoclast differentiation resulting from the loss of [Ca2+]i oscillation regulation. Yang S; Li YP Genes Dev; 2007 Jul; 21(14):1803-16. PubMed ID: 17626792 [TBL] [Abstract][Full Text] [Related]
78. Orai1-mediated calcium entry plays a critical role in osteoclast differentiation and function by regulating activation of the transcription factor NFATc1. Hwang SY; Putney JW FASEB J; 2012 Apr; 26(4):1484-92. PubMed ID: 22198385 [TBL] [Abstract][Full Text] [Related]
79. Actin-binding LIM protein 1 regulates receptor activator of NF-κB ligand-mediated osteoclast differentiation and motility. Jin SH; Kim H; Gu DR; Park KH; Lee YR; Choi Y; Lee SH BMB Rep; 2018 Jul; 51(7):356-361. PubMed ID: 29921413 [TBL] [Abstract][Full Text] [Related]
80. Tusc2/Fus1 regulates osteoclast differentiation through NF-κB and NFATc1. Kim I; Kim JH; Kim K; Seong S; Kim N BMB Rep; 2017 Sep; 50(9):454-459. PubMed ID: 28391779 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]